Rapamycin that inhibits mTOR and enhance autophagy has been reported to be beneficial in models of AD [59,60,61], HD [62,63,64], but detrimental in ALS models [65]. The gene discussed is MTOR; the disease is amyotrophic lateral sclerosis.